Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

JCO Early Release, published online ahead of print Aug 14 2006
Journal of Clinical Oncology, 10.1200/JCO.2006.07.5143

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hayes, D. F.
Right arrow Articles by Picard, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayes, D. F.
Right arrow Articles by Picard, M. H.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Heart of Darkness: The Downside of Trastuzumab

Daniel F. Hayes1 and Michael H. Picard2

1 Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
2 Cardiac Ultrasound Laboratory, Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Clin. Chem.Home page
Y. Xiao, X. Gao, S. Maragh, W. G. Telford, and A. Tona
Cell Lines as Candidate Reference Materials for Quality Control of ERBB2 Amplification and Expression Assays in Breast Cancer
Clin. Chem., July 1, 2009; 55(7): 1307 - 1315.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
I. Vanden Bempt, P. Van Loo, M. Drijkoningen, P. Neven, A. Smeets, M.-R. Christiaens, R. Paridaens, and C. De Wolf-Peeters
Polysomy 17 in Breast Cancer: Clinicopathologic Significance and Impact on HER-2 Testing
J. Clin. Oncol., October 20, 2008; 26(30): 4869 - 4874.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
C B Nunes, R M Rocha, J S Reis-Filho, M B Lambros, G F S Rocha, F S F Sanches, F N Oliveira, and H Gobbi
Comparative analysis of six different antibodies against Her2 including the novel rabbit monoclonal antibody (SP3) and chromogenic in situ hybridisation in breast carcinomas
J. Clin. Pathol., August 1, 2008; 61(8): 934 - 938.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
P. A. Ganz, M. A. Hussey, C. M. Moinpour, J. M. Unger, L. F. Hutchins, S. R. Dakhil, J. K. Giguere, J. W. Goodwin, S. Martino, and K. S. Albain
Late Cardiac Effects of Adjuvant Chemotherapy in Breast Cancer Survivors Treated on Southwest Oncology Group Protocol S8897
J. Clin. Oncol., March 10, 2008; 26(8): 1223 - 1230.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. C. Wolff, M. E. H. Hammond, J. N. Schwartz, K. L. Hagerty, D. C. Allred, R. J. Cote, M. Dowsett, P. L. Fitzgibbons, W. M. Hanna, A. Langer, et al.
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer
J. Clin. Oncol., January 1, 2007; 25(1): 118 - 145.
[Abstract] [Full Text] [PDF]


About
JCO		 Editorial
Roster		 Advertising
Information		 Librarians &
Institutions		 Rights &
Permissions		 PDA Services

Copyright © 2006 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online